Ligand Pharmaceuticals Inc (NASDAQ:LGND)

130.47
Delayed Data
As of Oct 15
 +0.50 / +0.39%
Today’s Change
78.26
Today|||52-Week Range
219.75
+31.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues71.9M109.0M141.1M251.5M
 
 
 
 
 
Cost of Goods Sold3.2M4.9M5.0M5.4M
 
 
 
 
 
Depreciation And Amortization2.6M11.3M12.5M16.7M
 
 
 
 
 
 
Operating ExpensesGross Income66.1M92.8M123.6M229.3M
 
 
 
 
 
General Expenses37.8M47.8M55.5M65.6M
 
 
 
 
 
Research And Development13.4M21.2M26.9M27.9M
 
 
 
 
 
Total Operating Expenses43.6M64.1M73.0M87.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income28.3M44.9M68.1M163.7M
 
 
 
 
 
Extraordinary Credit27.2M300.0K3.2M5.4M
 
 
 
 
 
Extraordinary Charge-5.8M-4.4M-2.6M0.00
 
 
 
 
Pre-Tax Equity Earnings-5.1M-23.1M-2.0M50.2M
 
 
 
 
 
Interest Expense On Debt11.8M12.2M11.4M48.3M
 
 
 
 
 
Other Expenses2.5M2.4M2.0M-11.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.3M8.0M57.2M173.3M
 
 
 
 
 
Income Taxes-192.1M-10.3M-44.7M-30.0M
 
 
 
 
 
Minority Interest-2.4M0.000.000.00
 
 
Extraordinary Items0.00731.0K0.000.00
 
 
Net Income229.8M-2.4M12.6M143.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.8M20.8M21.0M21.2M
 
 
 
 
 
Shares To Calculate EPS Diluted21.2M20.8M23.5M24.1M
 
 
 
 
 
 
Earnings Per ShareEPS$10.83-$0.08$0.53$5.96
 
 
 
 
 
EPS Diluted$10.83-$0.11$0.53$5.96